GARY W. PACE - 15 Sep 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ Gary Pace
Issuer symbol
CRDF
Transactions as of
15 Sep 2022
Net transactions value
+$256,500
Form type
4
Filing time
19 Sep 2022, 08:37:26 UTC
Previous filing
08 Jun 2022
Next filing
15 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRDF Common Stock Purchase $256,500 +150,000 +30% $1.71 644,811 15 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.65 to $1.78. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.